Investigating the impact of physical activity on mitochondrial function in Parkinson’s disease (PARKEX): Study protocol for A randomized controlled clinical trial
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0293774 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2023. Verfasst von Juan Carlos Magaña und 11 weiteren Autor:innen. Beteiligte Einrichtung: Facultat de Psicologia, Ciències de l'Educació i de l'Esport Blanquerna, Ramon Llull University, Barcelona, Spain. Hauptthemen laut MEDLINE: Quality of Life, Parkinson Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat Ramon Llull, Agência Regional para o Desenvolvimento da Investigação, Tecnologia e Inovação, Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Parkinson’s disease (PD) is characterized by the progressive dopaminergic neuron degeneration, resulting in striatal dopamine deficiency. Mitochondrial dysfunction and oxidative stress are associated with PD pathogenesis. Physical activity (PA) has been shown to ameliorate neurological impairments and to impede age-related neuronal loss. In addition, skin fibroblasts have been identified as surrogate indicators of pathogenic processes correlating with clinical measures. The PARKEX study aims to compare the effects of two different PA programs, analyzing the impact on mitochondrial function in patients’ skin fibroblasts as biomarkers for disease status and metabolic improvement. Early-stage PD patients (n = 24, H&Y stage I to III) will be randomized into three age- and sex-matched groups. Group 1 (n = 8) will undergo basic physical training (BPT) emphasizing strength and resistance. Group 2 (n = 8) will undergo BPT combined with functional exercises (BPTFE), targeting the sensorimotor pathways that are most affected in PD (proprioception-balance-coordination) together with cognitive and motor training (Dual task training). Group 3 (n = 8) will serve as control (sedentary group; Sed). Participants will perform three sessions per week for 12 weeks. Assessment of motor function, quality of life, sleep quality, cognitive aspects and humor will be conducted pre- and post-intervention. Patient skin fibroblasts will be collected before and after the intervention and characterized in terms of metabolic remodeling and mitochondrial bioenergetics. Ethical approval has been given to commence this study. This trial is registered at clinicaltrials.gov (NCT05963425). Trial registration. https://classic.clinicaltrials.gov/ct2/history/NCT05963425 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Facultat de Psicologia, Ciències de l'Educació i de l'Esport Blanquerna, Ramon Llull University, Barcelona, Spain.
- CNC-UC, Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
- CIBB, Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
- Facultat de Ciències de la Salut, Blanquerna, Ramon Llull University, Barcelona, Spain.
- Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Andorra.
- Universitat d'Andorra, Sant Julià de Lòria, Andorra.
ORCID-Profile: Juan Carlos Magaña, Joel Montane
Förderung
- Universitat Ramon Llull
- Agência Regional para o Desenvolvimento da Investigação, Tecnologia e Inovação
- Fundação para a Ciência e a Tecnologia
- FCT Pos-Doctoral fellowship
Zitieren
APA
Magaña, J. C., Deus, C. M., Baldellou, L., Avellanet, M., Gea-Rodríguez, E., Enriquez-Calzada, S., Laguna, A., Martínez-Vicente, M., Hernández-Vara, J., Giné-Garriga, M., Pereira, S. P., & Montane, J. (2023). Investigating the impact of physical activity on mitochondrial function in Parkinson’s disease (PARKEX): Study protocol for A randomized controlled clinical trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0293774
Vancouver
Magaña JC, Deus CM, Baldellou L, Avellanet M, Gea-Rodríguez E, Enriquez-Calzada S, et al. Investigating the impact of physical activity on mitochondrial function in Parkinson’s disease (PARKEX): Study protocol for A randomized controlled clinical trial. PLOS ONE. 2023. doi:10.1371/journal.pone.0293774
BibTeX
@article{Magaa2023,
author = {Magaña, Juan Carlos and Deus, Cláudia Maria and Baldellou, Laura and Avellanet, Merce and Gea-Rodríguez, Elvira and Enriquez-Calzada, Silvia and Laguna, Ariadna and Martínez-Vicente, Marta and Hernández-Vara, Jorge and Giné-Garriga, Maria and Pereira, Susana Patricia and Montane, Joel},
title = {Investigating the impact of physical activity on mitochondrial function in Parkinson’s disease (PARKEX): Study protocol for A randomized controlled clinical trial},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0293774}
}
EUVIMED